CellSource Income Statement

Financials in millions JPY. Fiscal year is November - October.

Millions JPY. Fiscal year is Nov - Oct.

Fiscal Year	TTM	FY 2025	FY 2023	FY 2022
Period Ending	Apr '26 Apr 30, 2026	Oct '25 Oct 31, 2025	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022
Revenue	3,666	3,711	4,511	4,274
Revenue Growth (YoY)	-19.74%	-17.73%	5.54%	-
Cost of Revenue	1,555	1,624	1,326	1,210
Gross Profit	2,111	2,087	3,185	3,064
Selling, General & Admin	1,835	1,920	1,136	812.85
Research & Development	-	-	72.45	87.56
Other Operating Expenses	-	-	733.79	575.73
Operating Expenses	1,835	1,920	1,963	1,493
Operating Income	276	167	1,222	1,571
Interest Expense	-1	-1	-0.38	-0.01
Interest & Investment Income	-	-	0.01	0.01
Earnings From Equity Investments	-	-	-3.08	-3.16
Currency Exchange Gain (Loss)	-	-	-8.4	20.63
Other Non Operating Income (Expenses)	-11	-1	-13.58	4.67
EBT Excluding Unusual Items	264	165	1,196	1,593
Gain (Loss) on Sale of Investments	-13	-13	33	-9.55
Gain (Loss) on Sale of Assets	1	2	-	-
Other Unusual Items	-46	-45	10.6	-
Pretax Income	195	109	1,240	1,584
Income Tax Expense	125	99	316.54	565.8
Net Income	70	10	923.14	1,018
Net Income to Common	70	10	923.14	1,018
Net Income Growth	-91.39%	-98.92%	-9.30%	-
Shares Outstanding (Basic)	20	20	19	19
Shares Outstanding (Diluted)	20	20	19	19
Shares Change (YoY)	1.31%	3.29%	0.25%	-
EPS (Basic)	3.53	0.50	48.88	54.54
EPS (Diluted)	3.53	0.50	47.93	52.98
EPS Growth	-91.49%	-98.95%	-9.53%	-
Free Cash Flow	416	290	498.62	752.89
Free Cash Flow Per Share	20.94	14.58	25.89	39.19
Dividend Per Share	5.000	5.000	5.000	-
Gross Margin	57.58%	56.24%	70.61%	71.70%
Operating Margin	7.53%	4.50%	27.08%	36.76%
Profit Margin	1.91%	0.27%	20.47%	23.82%
Free Cash Flow Margin	11.35%	7.81%	11.05%	17.62%
EBITDA	481	384	1,285	1,616
EBITDA Margin	13.12%	10.35%	28.50%	37.82%
D&A For EBITDA	205	217	63.85	45.42
EBIT	276	167	1,222	1,571
EBIT Margin	7.53%	4.50%	27.08%	36.76%
Effective Tax Rate	64.10%	90.83%	25.53%	35.73%
Advertising Expenses	-	-	32.81	39.44